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Congestive heart failure is a potentially debilitating disorder 
that affects a significant number of patients. The age-adjusted 
death rate has doubled over the past decade. Patients live an 
average of 4 to 5 years, and nearly all suffer from fatigue and 
breathlessness, which limits exercise capacity and produces a 
poor quality of life. Patients have usually been advised to avoid 
exercise because of concerns that they would experience a further 
decline in cardiac function. However, it has been demonstrated 
that exercise capacity is not related to the degree of left ventric- 
ular systolic dysfunction. This has led to the suggestion that 
peripheral changes in skeletal muscle and blood supply may play 
a major role in determining the exercise capacity of patients with 
congestive heart failure. Studies have demonstrated abnormalities 
of skeletal muscle blood flow, metabolism and structure, all of 
which are consistent with the impaired performance observed in 
these patients. Although the effects of exercise training have been 
examined in only a relatively few number of patients, the results 
have been promising. Exercise training has been found to improve 
exercise capacity and reduce symptoms. However, to our knowi. 
edge no data exist as to the impact of exercise training on left 
ventricular function, hospital stay or mortality in this population. 
Even though the early results are promising, they require confir- 
mation of feasibility, clinical benefit and safety in larger, long- 
term randomized trials. It should be determined whether training 
has a long-term beneficial impact on measures more closely 
related to daily activities and quality of life. Ultimately, it would be 
important to determine whether training has an impact on 
mortality and morbidity. 
(J Am Coll Cardiol 1995;25:789-96) 
Congestive heart failure is very prevalent and accounts for 
millions of hospital admissions each year (1,2). Over the past 
20 years, the death rate from congestive heart failure has 
increased considerably and is only partly explained by the aging 
of the population (2). Patients with heart failure live an 
average of -4  to 5 years (3), but nearly all suffer from fatigue 
and breathlessness that results in limited exercise capacity and 
poor quality of life. Traditionally, patients with heart failure 
have been advised to rest and avoid exercise because of 
concerns that their condition would further deteriorate. How- 
ever, several studies indicate that exercise capacity is not 
related to degree of ventricular systolic dysfunction and that 
factors in addition to the underlying myocardial dysfunction 
contribute to the development of clinical symptoms, functional 
limitation and adverse clinical outcomes. Exercise training 
might favorably alter these factors, leading to improved symp- 
toms, functional capacity and clinical outcomes. Conversely, 
limiting physical activity may not only be unnecessary but also 
undesirable because it could lead to further disability. In this 
review we discuss the rationale for exercise training and outline 
the limitations of the available data. We first describe the 
skeletal muscle abnormalities that occur in patients with 
congestive heart failure and the implications of a poor exercise 
capacity and review the effects of exercise training in reversing 
these abnormalities. Finally, we outline future directions for 
research in this area. We have not included pulmonary factors 
in the present review because they rarely limit exercise capac- 
ity, contribute only modestly to fatigue and have been recently 
described in two excellent publications (4,5). 
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L imi ta t ions  to Exerc i se  Capac i ty  in  Pat ients  
Wi th  Congest ive  Hear t  Fa i lu re  
Lack of relation between ventricular systolic dysfunction 
and exercise capacity. In patients with heart failure there has 
been no relation observed between left ventricular ejection 
fraction and peak exercise performance (6-10). Furthermore, 
peak oxygen uptake is not related to the change in left 
ventricular ejection fraction from rest to peak exercise (6,8). It 
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may be that the degree of right ventricular dysfunction atrest 
predicts exercise performance because in one study (11) a 
relation was found between peak exercise performance and 
right ventricular ejection fraction at rest. However, other 
studies (8,10) have found no relation between peak exercise 
performance and right ventricular ejection fraction. 
Maskin et al. (12) found that short-term infusion of dobut- 
amine produced an improvement in exercise cardiac output, 
but this was not associated with an increase in exercise 
performance. In another study (13) the response to short- and 
long-term (3 months) administration of cilazapril was com- 
pared in patients with congestive heart failure. Short-term 
administration of cilazapril improved central hemodynamic 
variables during exercise but not exercise performance, 
whereas long-term administration produced a further slight 
improvement in central hemodynamic variables and a signifi- 
cant increase in peak exercise oxygen uptake. 
These studies suggest he reduction in exercise capacity 
experienced by patients with heart failure may be more 
significantly influenced by factors other than poor ventricular 
function. 
Skeletal muscle abnormalities. Patients with congestive 
heart failure have been found to have a lower maximal muscle 
strength compared with healthy subjects (14,15) although this 
has not been found in all studies (16). This difference probably 
relates to patient selection because those in the study by Lipkin 
et al. (14) and Buller et al. (15) had severe heart failure, 
whereas those in the study by Minotti et al. (16) had a wider 
range of clinical heart failure. However, studies have consis- 
tently demonstrated that the development of fatigue for a 
given work load is greater in patients with heart failure than 
among healthy subjects (14-16). These findings have led to the 
suggestion that skeletal muscle abnormalities may contribute 
to the impairment of functional capacity observed in patients 
with heart failure. 
Skeletal muscle atrophy. Skeletal muscle atrophy is often 
observed in patients with congestive heart failure and can 
occur early in the course of the disease (14,17). Muscle atrophy 
may be related to diminished physical activity or circulating 
cytokine levels (18). Gas exchange measurements during exer- 
cise in healthy subjects would tend to support he hypothesis 
that a decreased muscle mass may partially contribute to the 
impairment ofexercise capacity (19). The gas exchange pattern 
in healthy subjects differs in relation to the amount of muscle 
mass used to perform exercise (e.g., treadmill exercise vs. 
two-leg cycle exercise vs. one-leg cycle exercise). A healthy 
subject cycling using one leg had a gas exchange pattern that 
was similar to a patient with mild congestive heart failure, 
suggesting that muscle atrophy may in part be responsible for 
the impairment of exercise capacity (19). Mancini et al. (17) 
recently assessed muscle mass in relation to exercise perfor- 
mance in 62 patients in New York Heart Association func- 
tional classes I to IV with an average jection fraction of 23 _+ 
12%. They found significant positive linear correlations be- 
tween peak exercise oxygen uptake and midarm circumfer- 
ence, muscle circumference, muscle area, skeletal muscle mass 
and creatinine height index. This suggests hat muscle atrophy 
contributes toeffort intolerance. However, when the work load 
is matched for the difference in work capacity or for muscle 
cross-sectional area, the abnormal muscle metabolism persists, 
suggesting that there are qualitative changes in skeletal muscle 
of patients with heart failure (17,20). 
Abnormalities ofskeletal muscle blood flow. Studies dating 
back to the 1930s (21-23) have suggested impaired blood flow 
to the skeletal muscles in patients with heart failure, and this 
has been confirmed in both human and animal studies (24-29). 
A number of potential mechanisms underlie the reduction in 
vasodilatory capacity, including a reduction in endothelium- 
derived relaxing factor and salt retention and increases in 
various vasoconstrictive n urohormones, such as endothelin, 
norepinephrine, r nin, angiotensin II and vasopressin (30-33). 
There is evidence from human and animal studies (26,34) that 
exercise training may improve skeletal muscle blood flow. The 
improvement in skeletal muscle blood flow during exercise is 
not related to improved central hemodynamic variables, occurs 
gradually after several weeks of training and appears to be 
related to improvements in exercise capacity (13,35). 
Abnormalities ofskeletal muscle metabolism. A reduction i  
skeletal muscle blood flow is not the only factor esponsible for 
the impairment of exercise performance in patients with 
congestive heart failure. An abnormality in intrinsic skeletal 
muscle performance may also contribute to the reduction in 
exercise performance (16). Muscle metabolism ofpatients with 
heart failure has been examined using phosphorus-31 magnetic 
resonance imaging (MRI) studies (36). 
Wilson et al. (37) used phosphorus-31 MRI to examine 
forearm muscle metabolism during exercise in nine patients 
with heart failure and eight age-matched control subjects. 
Exercise resulted in a pronounced increase in the inorganic 
phosphate/phosphocreatine ratio,and a pronounced decrease 
in pH in patients with heart failure, whereas the control group 
had only a moderate increase in the inorganic phosphate/ 
phosphocreatine ratio with a minimal decrease in pH. Massie 
et al. (20) performed a similar study that examined changes in 
forearm skeletal muscle metabolism in 11 patients with con- 
gestive heart failure and seven age-matched controls. In their 
study the increase in the inorganic phosphate/phosphocreatine 
ratio and decrease in pH found in forearm skeletal muscle 
during exercise were similar to the changes observed by Wilson 
et al. (37). The pronounced increase in the inorganic phos- 
phate/phosphocreatine ratio and decrease in pH could reflect 
a loss of muscle mass rather than an intrinsic muscle abnor- 
mality, but this possibility was excluded by a study (20) that 
found a reduction in phosphocreatine and pH at submaximal 
loads in patients with heart failure compared with that in 
control subjects (20). Massie et al. (38) studied nine patients 
with heart failure and nine control subjects who performed 
repetitive finger flexion at submaximal work loads while blood 
flow to the exercising muscle was totally occluded. The patients 
with heart failure continued to have a greater decline in 
phosphocreatine and pH during exercise than control subjects, 
consistent with a primary abnormality of muscle metabolism. 
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Therefore, the data would support a primary abnormality of 
muscle metabolism as the reason for impaired exercise perfor- 
mance rather than muscle atrophy or alterations in skeletal 
muscle blood flow. 
Some studies (39-41) in patients with heart failure have 
examined muscle metabolism during calf muscle (a weight- 
bearing muscle) exercise and found abnormalities similar to 
those in the forearm. The results from those studies would 
support the conclusion that in patients with heart failure there 
is an intrinsic abnormality in skeletal muscle metabolic func- 
tion. 
The mechanism by which these metabolic hanges impair 
exercise performance has not been elucidated. It may be that 
the early increase in inorganic phosphate and decrease in pH 
are responsible for producing premature fatigue in patients 
with heart failure. This is supported by studies (42,43) of 
skinned muscle fiber and isolated muscle preparations that 
suggest hat the increase in inorganic phosphate or H2PO 4 
interferes with muscle contraction. In human studies (44,45) 
there is a close relation between the increase in H2PO 4 and the 
decline in the force of maximal voluntary contraction during 
exercise. 
Histologic and biochemical bnormalities ofskeletal muscle. 
Lipkin et al. (14) noted a predominance of type II (fast-twitch 
muscle fibers) in patients with heart failure. Mancini et al. (46) 
compared results from 22 patients with heart failure with eight 
normal subjects. The patients were found to have smaller areas 
of type IIa and IIb fibers, a significant increase in the percent 
of type IIb fibers and a decrease in 3-hydroxyacyl-coenzyme A 
dehydrogenase activity. Citrate synthetase activity was normal, 
indicating normal oxidative nzyme levels, as were phospho- 
fructokinase levels, suggesting maintenance of glycolytic en- 
zymes. Sullivan et al. (47) examined 11 patients with long- 
standing congestive heart failure and 9 normal subjects. They 
found that the concentrations of the mitochondrial enzymes 
succinate dehydrogenase and citrate synthetase were signifi- 
cantly reduced compared with those in normal subjects. They 
also found a decrease in 3-hydroxyacyl-coenzyme A-dehydro- 
genase, glycogen content, a reduced percent of type I (slow 
twitch) and a higher percent of type lib fibers (although the 
cross-sectional rea of these fibers was decreased). Patients 
with congestive heart failure had a decrease in the number of 
capillaries per fiber but the ratio of capillaries to cross- 
sectional fiber area was not different between the two groups. 
Drexler et al. (48) examined the mitochondrial volume density 
and the surface density of mitochondrial cristae in 57 patients 
with congestive heart failure and 18 healthy control subjects. 
They found a significant 20% reduction in mitrochondrial 
volume density and surface density of mitochrondial cristae in 
patients with congestive heart failure. There was a significant 
reduction i  cytochrome oxidase activity in mitochondria and a 
shift in fiber type distribution to type II. Mitrochondrial 
volume density and surface density of mitochrondial cristae 
were significantly related to peak exercise oxygen uptake and 
to oxygen uptake at anaerobic threshold. The mitrochondrial 
volume density was found to be inversely related to the 
duration of congestive heart failure. In a subgroup of patients 
who underwent repeat biopsies at 4 months, a relation was 
found between the change in mitrochondrial volume density 
and in peak exercise oxygen uptake. 
Impl icat ions  of Poor  Exercise Capacity 
Psychologic effects. Limiting physical activity has adverse 
psychologic effects, whereas physical exercise could improve 
quality of life because patients that become fitter and stronger 
could be expected to be more comfortable performing tasks of 
daily living, leading to increased independence, l ss chronic 
illness behavior and less depression (49). Coats et al. (50) 
assessed symptoms and daily activity scores in patients with 
congestive heart failure after 8 weeks of exercise training. They 
found a significant decrease in symptoms (less dyspnea nd 
fatigue) and an improvement i  daily activity scores (as well as 
ease with which activities were performed). 
Effects on autonomic nervous system. Patients with con- 
gestive heart failure have a marked activation of various 
neurohormonal mechanisms, including elevation of renin, cir- 
culating catecholamines atrial naturetic factor and arginine 
vasopressin (32). These changes increase peripheral vascular 
resistance and decrease blood flow to various organs, including 
skeletal muscles. The degree of elevation of norepinephrine 
(51) or decrease invagal tone (52,53) has been shown to be an 
independent risk factor for death. Exercise training has been 
shown to reduce rest plasma catecholamine levels (54), en- 
hance heart rate variability and improve baroreflex gain, 
reflecting an increase in vagal tone (55). A study in dogs with 
experimentally induced myocardial infarction (56) demon- 
strated that exercise conditioning increased the ventricular 
fibrillation threshold through an increase in vagal and a 
decrease in sympathetic tone. 
Coats et al. (50) used heart rate variability, autoregressive 
power spectral analysis of the rest electrocardiogram and 
whole-body radiolabeled norepinephrine spillover to assess 
autonomic nervous ystem function in 17 patients with conges- 
tive heart failure after 8 weeks of training. Each of these 
methods demonstrated a significant shift away from sympa- 
thetic toward enhanced vagal activity after training. These 
favorable ffects of exercise on the autonomic nervous ystem 
might be expected to improve prognosis by reducing the 
incidence of sudden death. 
Effects on mortality and morbidity. In a recent study 
Bittner et al. (57) examined the relation between a6-min walk 
test distance and mortality/morbidity in >800 patients with left 
ventricular dysfunction who were a subset of those recruited to 
the Studies of Left Ventricular Dysfunction (58). The 6-rain 
walk test is a self-paced submaximal exercise test in which the 
patient walks around a set course and is able to rest if required 
during the test. Total distance walked in 6 min is the primary 
measurement, but symptoms and reasons for rest periods if 
they are required are also recorded. That study demonstrated 
that patients who had a better 6-rain walk test performance 
had lower mortality/morbidity (hospital admission) rates. The 
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relation between 6-min walk test performance and mortality/ 
morbidity rate was independent of left ventricular function and 
only moderately correlated with functional classification. 
A number of studies have demonstrated that in subjects 
without overt findings of heart disease, a sedentary life-style 
increases the risk a cardiovascular event (59-62), whereas in 
those who participate in regular physical activity, incidence of 
cardiovascular events is reduced (59,61). Furthermore, meta- 
analyses of the randomized trials of exercise rehabilitation i
postinfarction patients have found a 20% to 25% reduction i  
mortality in the training roup (63-65). These results suggest 
that exercise capacity might be a modifiable independent 
prognostic factor. Improvement of exercise capacity may de- 
crease both mortality and morbidity in patients with congestive 
heart failure. 
Exercise Train ing in Pat ients With 
Congest ive Heart  Fai lure 
Effects of training on skeletal muscle abnormalities found 
in patients with congestive heart failure. Biochemical and 
histologic hanges observed with congestive heart failure are 
similar to those found with deconditioning (66-68). Minotti et 
al. (69) studied patients with congestive heart failure who 
performed single-arm training for 28 days. Although no change 
was observed in the size of the trained forearm flexor muscle, 
a twofold to threefold increase in endurance associated with a 
slower increase in inorganic phosphate and a decline in 
phosphocreatine with a decrease in the inorganic phosphate/ 
phosphocreatine ratio versus work load slope was observed, 
indicating an improvement in oxidative metabolism. Adamo- 
poulos et al. (41) examined the metabolic hanges in the 
gastrocnemius muscle after 8 weeks of home-based cycle 
exercise training. There was an improvement i  plantar flexion 
exercise tolerance, which was associated with a reduction in 
phosphocreatine depletion, less adenosine diphosphate during 
exercise and an increase in phosphocreatine resynthesis rate 
during the recovery period. These changes uggest that exer- 
cise training may improve the impaired oxidative capacity of 
skeletal muscle found in patients with congestive heart failure. 
Sullivan et al. (26) also found that exercise training in patients 
with congestive heart failure resulted in a lessening of the 
metabolic abnormalities observed before training. 
Although the data would suggest that exercise training in 
patients may lead to a reversal of skeletal muscle abnormali- 
ties, with associated improvements in functional capacity and 
quality of life, there have been relatively few studies designed 
to address this hypothesis. Furthermore, the total number of 
patients who have been examined in these studies is relatively 
small (Table 1). These studies are summarized next. 
Uncontrolled or nonranflomized studies. Six studies have 
examined the effects of exercise training in patients with 
congestive heart failure using a study design that did not 
include randomization r a control group (Table 1). There has 
been considerable variation in the type of exercise training and 
follow-up period in these studies. 
Lee et al. (70) studied 18 patients with a previous myocar- 
dial infarction and an average jection fraction of 18% who 
were in functional classes I to III. The patients were instructed 
to train at 70% to 85% of their maximal heart rate for 20 to 
45 rain -4  days/week. Training continued for an average of 19 
months and resulted in an improved incremental exercise time 
by 1.1 min, with no change in left ventricular ejection fraction. 
Connet al. (71) studied 10 patients who had a myocardial 
infarction >3 months earlier, had an average jection fraction 
of 20% and trained three to five sessions per week, 35 to 45 
min/session for an average of 13 months. After training, they 
found an increase in exercise performance of 1.5 metabolic 
equivalents (MET). 
Arvan (72) evaluated 25 postinfarction patients with an 
ejection fraction <40% who trained at 75% to 85% of peak 
oxygen uptake for 30 to 45 rain three times a week. After 12 
weeks of training there was a significant improvement in peak 
oxygen uptake of 7 ml/min per kg. However, 11 of these 25 
patients had ischemia during exercise testing, and the improve- 
ment in peak oxygen uptake after training was only 3 ml/min 
per kg. The 14 patients without ischemia during exercise 
testing had an l l-ml/min per kg increase in peak oxygen 
uptake after training. These results suggest that the presence 
of myocardial ischemia may have limited the amount of benefit 
derived from exercise training in these patients. 
Sullivan et al. (26) studied 12 patients with congestive heart 
failure with ejection fraction of 9% to 33% who were in 
functional c asses I to III. The patients trained for 60 min three 
to five times a week at 75% of their peak oxygen uptake. After 
16 to 24 weeks of training, the patients had a 3.8-ml/min per kg 
increase in peak oxygen uptake, a 1.6-ml/dl increase in leg 
arteriovenous oxygen difference and a 0.5-1iter/min increase in 
peak exercise leg blood flow. 
Jugdutt et al. (73) recruited 22 patients who had experi- 
enced an anterior myocardial infarction 6 to 32 weeks before 
study entry and who performed calisthenics (Canadian Air 
Force 5Bx Program) and stationary running every day for 12 
weeks. The results demonstrated that patients with total left 
ventricular asynergy >18% (representing a large myocardial 
infarction) had a further increase in the amount of asynergy 
and a decline in ejection fraction (from 43% to 30%) after 
training. However, these results should be interpreted cau- 
tiously because the study had a number of limitations, such as 
a nonrandomized control group, small sample size and poorly 
standardized xercise program, and the determination f asyn- 
ergy was made from the echocardiographic short-axis view 
only. Other better designed studies did not find a deterioration 
in left ventricular function in patients who exercised soon after 
anterior wall myocardial infarction (74,75). 
Baigrie et al. (76) recruited 17 patients with congestive 
heart failure with an average jection fraction of 21% for a 
supervised 16-week walking program. There was no control or 
usual care group included in that study. After training there 
was an improvement i  peak oxygen uptake of 1.4 ml/min per 
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kg, an increase in 6-min walk test distance of 85 m and 
improvement in quality of life. 
Randomized, controlled trials. Coats et al. (50,77) re- 
cruited 17 patients with congestive heart failure with an 
average jection fraction of 20% for a random-order crossover 
design trial. The patients trained on a cycle ergometer athome 
at 70% to 80% of peak heart rate for 20 rain 5 days/week for 
8 weeks. After training there was a significant improvement i  
peak oxygen uptake of 2.4 ml/min per kg, significant lowering 
of symptom scores and significant reduction in sympathetic 
activity with enhanced vagal tone. 
Jett6 et al. (74) randomized 10 patients with congestive 
heart failure for an exercise program and 8 for usual treatment. 
The patients trained for 55 rain in the morning and 30 to 
60 min in the afternoon 5 days/week for 4 weeks. A significant 
improvement i  peak oxygen uptake from 1.0 to 1.2 liters/min 
was observed after training. There was no significant change in 
ejection fraction observed after training. 
Limitations of Available Data 
Although there are physiologic reasons why exercise train- 
ing could be beneficial in patients with congestive heart failure, 
no data currently exist to indicate that it produces worthwhile 
clinical benefits, that there is an acceptable balance between 
risk and benefit or how well patients will comply over the long 
term. Only aerobic exercise training has been examined, and 
this form of training does not specifically improve muscle 
strength. Resistance (weightlifting) training, which specifically 
improves muscle strength, is now routinely used in patients 
with coronary artery disease (78,79) but has not been advo- 
cated for patients with congestive heart failure because of 
concerns about he hemodynamic response. Recently we dem- 
onstrated (88) that resistance xercise produces hemodynamic 
responses that are no greater than those found with cycling, 
suggesting that patients could safely participate in a combined 
aerobic and resistance training program. 
The safety of exercise training in patients with heart failure 
has not been examined in detail because of the limited number 
of patients who have been enrolled in randomized studies. 
There are two lines of evidence that suggest hat properly 
prescribed training may be safe in these patients. The first, 
from a study of 607 patients with heart failure who performed 
symptom-limited xercise testing, did not find major compli- 
cations or frequent arrhythmias during testing (81). Second, in 
studies performed to date there has been no report of signif- 
icant complications despite rather high intensity training pro- 
tocols (Table 1). Therefore, although more studies are re- 
quired to better define the risk of exercise training in this 
population, the preliminary data do not indicate clear evidence 
of harm from exercise training. 
We have recently initiated arandomized, controlled, single- 
blind trial (Exercise Rehabilitation Trial in Congestive Heart 
Failure Patients [EXERT]) designed to examine the short- and 
long-term effects of combined aerobic and resistance training 
in patients with congestive heart failure. Ninety patients will be 
randomized tothe usual care group (no exercise training) and 
90 to a combined aerobic and resistance training program. The 
study will evaluate whether exercise training improves func- 
tional capacity and quality of life over the short (3 months) and 
long (12 months) term. Furthermore, the effects on left 
ventricular ejection fraction and volumes and on clinical events 
will be determined toassess afety. 
We greatly appreciate the secretarial ssistance provided by Chris Steffann. 
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